Quantum Biopharma plans voluntary delisting of Class B shares in Canada
Quantum Biopharma said it plans to voluntarily delist its Class B shares from the Canadian Securities Exchange.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.